Neurocrine Biosciences target price raised to $190 from $187 by RBC
NBIX•RBC raised its target price for Neurocrine Biosciences to $190 from $187.
Related News
Gildan Activewear Inc.: Scotiabank cuts target price to $53 from $67
GIL•
Arch Capital Group Ltd.: JPMorgan raises target price to $115 from $113
ACGL•
Stephens cuts Alphatec Holdings target price to $9 from $15
ATEC•
ExxonMobil: Gerdes Energy Research raises target price by $1 to $162
XOM•
Tempus AI upgraded to hold from underperform; price target raised to $70 from $35
TEM•